Recent advances in catheter devices for patent foramen ovale closure.


Journal

Expert review of medical devices
ISSN: 1745-2422
Titre abrégé: Expert Rev Med Devices
Pays: England
ID NLM: 101230445

Informations de publication

Date de publication:
Jan 2023
Historique:
pubmed: 20 1 2023
medline: 7 2 2023
entrez: 19 1 2023
Statut: ppublish

Résumé

Over the last 5 years, the armamentarium of the interventional cardiologist dealing with percutaneous closure of patent foramen ovale (PFO) has been enriched by some novel devices and further improvements of existing ones that have or promise to increase the safety and effective closure rate of PFO patients. This review presents and discusses recent advancements in device design and composition from both technical and clinical perspectives. Device technology is continuously evolving. The recent modification of delivery system, device hooking, and composition, as well as the advent of new bioabsorbable materials, is promising to make percutaneous PFO closure devices safer. The search for more effectiveness with possibly less metal behind is still ongoing.

Identifiants

pubmed: 36656563
doi: 10.1080/17434440.2023.2170782
doi:

Types de publication

Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-34

Auteurs

Gianluca Rigatelli (G)

Interventional Cardiology Unit, Division of Cardiology, Ospedali Riuniti Padova Sud, Padova, Italy.

Marco Zuin (M)

Department of Translational Medicine, University of Ferrara, Ferrara, Italy.

Giulio Rodinò (G)

Interventional Cardiology Unit, Division of Cardiology, Ospedali Riuniti Padova Sud, Padova, Italy.

Giuseppe Marchese (G)

Interventional Cardiology Unit, Division of Cardiology, Ospedali Riuniti Padova Sud, Padova, Italy.

Giampaolo Pasquetto (G)

Interventional Cardiology Unit, Division of Cardiology, Ospedali Riuniti Padova Sud, Padova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH